Procedure for use of cells derived from adipose tissue in the treatment of cardiovascular affections.

Use of a concentrated population of cells comprising stem cells derived from adipose tissue in the manufacture of a medicament for the treatment of a disorder characterized by insufficient cardiac function, insufficient perfusion, damaged myocardium or remodeling of cardiac tissue.